Arcadia Biosciences, Inc. (RKDA) |
|
0.295 0.011 (3.87%)
|
02-03 15:53 |
|
Open: |
0.29 |
Pre. Close: |
0.284 |
|
High:
|
0.2986 |
Low:
|
0.2859 |
|
Volume:
|
395,645 |
Market Cap:
|
7(M) |
|
|
|
Technical analysis |
as of: 2023-02-03 3:50:28 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 0.39 One year: 0.49 |
| Support: |
Support1: 0.2 Support2: 0.16 |
| Resistance: |
Resistance1: 0.33 Resistance2: 0.42 |
| Pivot: |
0.32  |
| Moving Average: |
MA(5): 0.28 MA(20): 0.32
MA(100): 0.38 MA(250): 0.82 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 37.1  %D(3): 32.3 |
| RSI: |
RSI(14): 45.3 |
| 52-week: |
High: 2.66 Low: 0.2 |
| Average Vol(K): |
3-Month: 233 (K) 10-Days: 587 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ RKDA ] has closed above bottom band by 27.8%. Bollinger Bands are 20% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.29 - 0.29 |
0.29 - 0.29 |
|
Low:
|
0.27 - 0.27 |
0.27 - 0.27 |
|
Close:
|
0.28 - 0.28 |
0.28 - 0.29 |
|
Company Description |
|
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California. |
Headline News |
Thu, 02 Feb 2023
An average trading volume for Arcadia Biosciences Inc. (RKDA) has ... - The Dwinnex
Wed, 01 Feb 2023
Should You Buy Arcadia Biosciences Inc (RKDA) Stock After it Is Lower By 17.65% in a Week? - InvestorsObserver
Wed, 01 Feb 2023
Arcadia Biosciences Inc. (NASDAQ: RKDA): Why Investors Shouldn't ... - Marketing Sentinel
Wed, 01 Feb 2023
4 Cheapest Defensive Stocks You Should Think About By Benzinga - Investing.com UK
Wed, 18 Jan 2023
GoodWheat™ Pasta Receives American Heart Association® Heart ... - PR Newswire
Thu, 08 Dec 2022
Arcadia Biosciences (RKDA) Doubles Retail Footprint for GoodWheat™ Pasta - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Basic Materials |
| Industry: Agricultural Inputs |
| Shares Out. |
22 (M) |
| Shares Float |
21 (M) |
|
% Held by Insiders
|
7.1 (%) |
|
% Held by Institutions
|
6.8 (%) |
|
Shares Short
|
380 (K) |
|
Shares Short P.Month
|
420 (K) |
Stock Financials |
|
EPS
|
-0.47 |
|
EPS Est Next Qtl
|
-0.08 |
|
EPS Est This Year
|
-0.37 |
|
EPS Est Next Year
|
-0.22 |
|
Book Value (p.s.)
|
2.05 |
|
Profit Margin (%)
|
-169.7 |
|
Operating Margin (%)
|
-187.6 |
|
Return on Assets (ttm)
|
-25.8 |
|
Return on Equity (ttm)
|
-60 |
|
Qtrly Rev. Growth
|
174.6 |
|
Gross Profit (p.s.)
|
0.07 |
|
Sales Per Share
|
0.52 |
|
EBITDA (p.s.)
|
-0.95 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-23 (M) |
|
Levered Free Cash Flow
|
-14 (M) |
Stock Valuations |
|
PE Ratio
|
-0.63 |
|
PEG Ratio
|
-0.1 |
|
Price to Book value
|
0.14 |
|
Price to Sales
|
0.56 |
|
Price to Cash Flow
|
-0.29 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2018-01-23 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
